Skip to content

Prospective Cohort Study of Bachmann Bundle Versus Right Atrial Appendage Pacing: Impact on Atrial Cardiomyopathy Evaluated by Echocardiographic Parameters and Clinical Outcome

Prospective Cohort Study of Bachmann Bundle Versus Right Atrial Appendage Pacing: Impact on Atrial Cardiomyopathy Evaluated by Echocardiographic Parameters and Clinical Outcome

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07360067
Acronym
BRAVE
Enrollment
200
Registered
2026-01-22
Start date
2025-12-09
Completion date
2028-12-31
Last updated
2026-07-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sick Sinus Syndrome

Keywords

bachmann bundle pacing

Brief summary

The goal of this observational study is to evaluate the impact of different atrial pacing sites-Bachmann's bundle pacing versus right atrial appendage pacing-on the development and progression of atrial cardiomyopathy in patients diagnosed with sick sinus syndrome who are undergoing permanent pacemaker implantation.

Detailed description

Previous studies have reported that conventional Right Atrial Appendage pacing is associated with delayed atrial activation time. A higher burden of atrial pacing at this site has been linked to an increased incidence of atrial fibrillation and atrial tachycardia. Furthermore, structural and functional deterioration of the atria-specifically Left Atrial dilation and reduced left atrial strain-has been observed in patients with a high percentage of Right Atrial Appendage pacing. These changes are known to accelerate the progression of atrial cardiomyopathy, potentially leading to adverse long-term clinical outcomes. To address these limitations, Bachmann Bundle Pacing has emerged as a promising alternative pacing site. The Bachmann bundle is a major atrial myoarchitecture connecting the right and left atria. Pacing at this site is expected to facilitate interatrial conduction, thereby restoring interatrial synchrony and mitigating interatrial block. Prior research indicates that pacing at the Bachmann bundle is associated with a reduced incidence of atrial fibrillation and atrial tachycardia, suggesting distinct benefits regarding atrial electrophysiological outcomes. However, existing studies have primarily focused on electrophysiological parameters, such as arrhythmia incidence. Consequently, the impact of Bachmann Bundle Pacing on atrial structural and functional remodeling remains to be clearly elucidated. Therefore, this study is designed as a single-center cohort study enrolling a total of 200 subjects (100 prospective and 100 retrospective). The investigators will analyze echocardiographic parameters over a 12-month period following pacemaker implantation. By comprehensively analyzing imaging parameters (left atrial/right atrial strain and volume changes assessed via echocardiography) and clinical outcomes (atrial arrhythmias, heart failure hospitalization, and mortality), this study aims to investigate the differential effects of Bachmann Bundle Pacing versus Right Atrial Appendage pacing on the development and progression of atrial cardiomyopathy.

Interventions

Atrial lead positioned in the right atrial appendage

Atrial lead positioned in the bachmann bundle branch

Sponsors

Samsung Medical Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients aged 19 years or older * Patients diagnosed with sick sinus syndrome who are scheduled for de novo implantation of a permanent pacemaker or permanent implantable cardioverter-defibrillator * Patients or their legal representatives who voluntarily consent to the access of medical records and study data throughout the entire research period

Exclusion criteria

* Patients with persistent or permanent AF * Patients with a life expectancy of less than one year due to other comorbidities * Pregnant or breastfeeding women * Patients who refuse active treatment

Design outcomes

Primary

MeasureTime frameDescription
Structural echocardiographic parameters of the left atrium6 and 12 months after pacemaker implantationLA Volume Index measured as mL/m\^2
Functional echocardiographic parameters of the left atrium6 and 12 months after pacemaker implantationReservoir Strain (%), Conduit Strain (%), Contraction Strain (%)

Secondary

MeasureTime frameDescription
Structural echocardiographic parameters of the left ventricle6 and 12 months after pacemaker implantationLV End-Diastolic Diameter(mm), LV End-Systolic Diameter(mm)
Functional echocardiographic parameters of the left ventricle6 and 12 months after pacemaker implantationLV Ejection Fraction (%), Global Longitudinal Strain (%)
Mitral and tricuspid regurgitation volume6 and 12 months after pacemaker implantationas mL per beat
Structural echocardiographic parameters of the right atrium6 and 12 months after pacemaker implantationRA Volume Index (mL/m\^2)
Functional echocardiographic parameters of the right atrium6 and 12 months after pacemaker implantationRA Reservoir Strain (%), RA Conduit Strain (%), RA Contraction Strain (%)
ECG parameters6 and 12 months after pacemaker implantationPR interval (ms), QRS duration (ms), P wave duration (ms), QTC (ms)
Average heart rate6 and 12 months after pacemaker implantationbpm
Heart rate distribution6 and 12 months after pacemaker implantationpercentage (%)
Pacing burden6 and 12 months after pacemaker implantationpercentage (%)
Atrial fibrillation burden6 and 12 months after pacemaker implantationpercentage (%)
atrial fibrillation occurrence6 and 12 months after pacemaker implantationcount
NTproBNP6 and 12 months after pacemaker implantationpg/ml
Procedure-related complications6 and 12 months after pacemaker implantationcount
Pacemaker/Implantable cardioverter defibrillator parameters6 and 12 months after pacemaker implantationThreshold (V)
Cardiac mortality6 and 12 months after pacemaker implantationcount
All-cause mortality6 and 12 months after pacemaker implantationcount
Patient's functional status6 and 12 months after pacemaker implantationNYHA class I\~IV
hospitalization due to heart failure6 and 12 months post-procedurecount
re-admission due to any cause6 and 12 months post-procedurecount
Cerebrovascular event6 and 12 months post-procedurecount

Countries

South Korea

Contacts

CONTACTJuwon Kim, MD
abcd186a@naver.com82+ 10-2079-8154
CONTACTJu Hee Lee, Bachelor
phacyde12@gmail.com82+ 10-7180-3357

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 29, 2026